Fullerene (C60) immunoconjugates: interaction of water-soluble C60 derivatives with the murine anti-gp240 melanoma antibody.
about
Current applications and future prospects of nanomaterials in tumor therapyWater-soluble fullerene (C60) derivatives as nonviral gene-delivery vectors.A new era of cancer treatment: carbon nanotubes as drug delivery tools.Internalization of C60 fullerenes into cancer cells with accumulation in the nucleus via the nuclear pore complex.Study of the cytotoxic effects of the new synthetic Isothiocyanate CM9 and its fullerene derivative on human T-leukemia cells.Interaction of human serum album and C₆₀ aggregates in solution.Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer.Cell Internalization Studies of Gadofullerene-(ZME-018) Immunoconjugates into A375m Melanoma Cells.Nanoparticle-based targeted drug deliveryAdvances and challenges of nanotechnology-based drug delivery systems.Targeted nanomaterials for radiotherapy.Recent advances in nanooncology.Detecting and treating cancer with nanotechnology.Advancement in carbon nanotubes: basics, biomedical applications and toxicity.Making carbon nanotubes biocompatible and biodegradable.Stimuli-responsive water-soluble fullerene (C60) polymeric systems.Nanomedicine: de novo design of nanodrugs.Recent updates in utilizing prodrugs in drug delivery (2013-2015).Dendrimer-Fullerenol Soft-Condensed Nanoassembly.C60 Fullerenes Diminish Muscle Fatigue in Rats Comparable to N-acetylcysteine or β-Alanine.Beyond the lipid-bilayer: interaction of polymers and nanoparticles with membranesContinuous Flow Synthesis of Methanofullerenes in Microstructured Reactors: A Kinetic Study
P2860
Q29248618-225C3C22-B9CB-4043-845B-C0706CBC9697Q31156684-61F39BA1-0766-44A6-B005-0422FAB354C1Q34097540-D51E247B-1F3F-47A5-8ECC-2E540A12DCF5Q34127719-10A048E5-4074-4CC6-9D90-A6E60EF96F77Q35131562-9443989E-A8F5-4B59-B980-7BB850CFD76FQ35229465-15E04344-660D-4C6F-AA94-8BC44365807CQ35578037-0AEA7605-9F26-497E-89AB-8A07148B0828Q35626517-2B5F085B-8D74-4515-917C-AB28104177D8Q35644991-CBF68E40-8291-4EBE-AFF7-C21C383E3A4AQ36985900-EDA0A398-827C-49D5-BDD5-5960B06F8F21Q37038825-A75C8C02-6225-43BB-8BFC-A7E540563267Q37058424-D4D1A9ED-7E17-4A26-80E8-22478231A814Q37089855-55053A76-F44C-4E83-A95E-FB1885DE4F75Q37828625-4450AC50-63BB-4297-8598-B6C3F0973497Q37903284-762A31D2-052E-42CF-B429-FE5114EA95AEQ37945539-B1599935-ABA8-4360-8EEE-630F558D1668Q38168683-0152B266-DE1C-4ADA-B190-4C259E8CED7BQ38702949-39D4ED89-B848-4971-8A46-256DF064A2B2Q41828400-748B9991-2131-4A7E-ABEF-DE86181FACC1Q54963897-1019AB83-6376-41D1-802B-BA36CEBB95D8Q57376603-15F69EDB-FC04-49AD-BC3F-1C42A0DA5705Q58561048-C66B923F-5A94-4647-A588-A7A2F026F276
P2860
Fullerene (C60) immunoconjugates: interaction of water-soluble C60 derivatives with the murine anti-gp240 melanoma antibody.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Fullerene (C60) immunoconjugat ...... anti-gp240 melanoma antibody.
@ast
Fullerene (C60) immunoconjugat ...... anti-gp240 melanoma antibody.
@en
type
label
Fullerene (C60) immunoconjugat ...... anti-gp240 melanoma antibody.
@ast
Fullerene (C60) immunoconjugat ...... anti-gp240 melanoma antibody.
@en
prefLabel
Fullerene (C60) immunoconjugat ...... anti-gp240 melanoma antibody.
@ast
Fullerene (C60) immunoconjugat ...... anti-gp240 melanoma antibody.
@en
P2093
P356
P1476
Fullerene (C60) immunoconjugat ...... e anti-gp240 melanoma antibody
@en
P2093
Dmitri A Tsyboulski
Jared M Ashcroft
John W Marks
Keith B Hartman
Lon J Wilson
Michael G Rosenblum
Tatiana Y Zakharian
P2860
P304
P356
10.1039/B601717G
P407
P577
2006-06-09T00:00:00Z